REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
VANTAI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/27/2026
Trademark type
Word
Nice classes
35, 42
Filing date
01/14/2020
Registration date
07/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2019-08-00
First use in commerce
2019-08-00
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
LE, MARGARET
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VantAI, Inc.
Vant AI, Inc.
Representatives
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and advisory services in the field of healthcarepharmaceuticals and biomedicine; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market data; systematization and compilation of data in computer databasesin particular compilation of information into computer databases for research and analysis purposes in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; business services provided to the healthcare industrythe collectionreportingprofessional business analysis of healthcare data for drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analyticsIT asset management and analyticssecurity management and analyticsmobility management and analyticsservice management and analyticsuser workspace and desktop system managementcustomer relationship managementuser permission and authorization management and supply chain management
Class 42
Computer analysis of technical research data in the field of healthcarepharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software allowing to connect to databases containing pharmaceutical and medical information related to drug research and development; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical information; providing temporary use of online non-downloadable computer software for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical drug research and developmentclinical and post-market trials for drug research and development; statistical analysis and reporting for pharmaceutical and biomedical research enabled by artificial intelligence and machine learning for the purpose of drug research and development; none of the foregoing services include the provision and maintenance of software for use in computer and IT systems management and analyticsIT asset management and analyticssecurity management and analyticsmobility management and analyticsservice management and analyticsuser workspace and desktop system managementcustomer relationship managementuser permission and authorization management and supply chain management
Publications
History of USPTO decisions and trademark events.
36 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/17/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/09/2021
APET
ASSIGNED TO PETITION STAFF
06/08/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/07/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/26/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2020
PUBO
PUBLISHED FOR OPPOSITION
12/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/30/2020
GNRT
NON-FINAL ACTION E-MAILED
04/30/2020
CNRT
NON-FINAL ACTION WRITTEN
04/30/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/29/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/28/2020
ALIE
ASSIGNED TO LIE
04/13/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2020
DOCK
ASSIGNED TO EXAMINER
04/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2020
NWAP
NEW APPLICATION ENTERED
01/17/2020
Continuous trademark protection
Get notified about every new filing that threatens VANTAI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.